首页> 外文期刊>The journal of ECT >Takotsubo cardiomyopathy after electroconvulsive therapy: a case report and review.
【24h】

Takotsubo cardiomyopathy after electroconvulsive therapy: a case report and review.

机译:电痉挛治疗后的Takotsubo心肌病:一例病例报告和审查。

获取原文
获取原文并翻译 | 示例
           

摘要

Takotsubo cardiomyopathy (TCM) is a syndrome of reversible stress-induced cardiomyopathy associated with profound emotional stress and a variety of medical illnesses and procedures, including electroconvulsive therapy (ECT). We describe 1 case of ECT-induced TCM followed by a successful retrial of ECT. We further discuss the management of ECT-induced TCM and the decision to perform a second trial of ECT in patients with this complication. Given the current understanding of the pathogenesis of TCM, it is appropriate to discontinue ECT during the acute setting of TCM. After the resolution of the acute episode of TCM, a second trial of ECT may be warranted depending on the severity of psychiatric illness (ie, suicidal ideation, catatonia, psychotic symptoms). If a retrial of ECT is performed, oral and intravenous beta-blockers should be used for cardioprotection, and patients should be monitored for signs and symptoms of an evolving cardiomyopathy. It is preferable to perform retrials of ECT-at least initially-in a general hospital setting, where immediate invasive monitoring and intensive treatments are available in the event of acute cardiac failure.
机译:Takotsubo心肌病(TCM)是一种可逆的压力诱发型心肌病综合征,与严重的情绪压力以及包括电惊厥疗法(ECT)在内的多种医学疾病和程序有关。我们描述1例ECT诱发的中医,然后成功重试ECT。我们将进一步讨论ECT引起的中医的治疗以及对这种并发症患者进行ECT的第二次试验的决定。鉴于目前对中医发病机制的了解,在中医急性发作期间中止ECT是适当的。在中医急性发作解决后,可能需要进行ECT的第二项试验,具体取决于精神疾病的严重程度(即自杀意念,卡塔尼亚症,精神病性症状)。如果进行了ECT再试验,则应使用口服和静脉内β受体阻滞剂进行心脏保护,并应监测患者病情发展的心肌病的体征和症状。最好至少在初期在普通医院进行ECT的重试,在这种情况下,如果发生急性心力衰竭,可以立即进行侵入性监测和强化治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号